Prof. Eran Elinav, M.D., Ph.D. is a professor at the Department of Immunology, Weizmann Institute of Science, and director of the cancer-microbiome division, DKFZ, Heidelberg, Germany. He focuses on deciphering the molecular basis of host-microbiome interactions and their effects on health and disease, with a goal of personalizing medicine and nutrition. Prof. Elinav has published more than 200 publications in leading journals on the effects of host genetics, innate immune function and diet on the microbiome and its propensity to drive multi-factorial disease. His honors include the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine, the Alon Foundation award, the Rappaport prize for biomedical research, the Levinson award (2016), and the Landau prize (2018). He is an elected member at the Canadian Institute For Advanced Research (CIFAR), the European Molecular Biology Organization (EMBO), the Howard Hughes Medical Institute (HHMI) and the Bill & Melinda Gates Foundation.